360 Stem Cell & Regenerative Medicine Newsletter - Special Event Notice

 weSRCH's Best of the Internet Award

360 Stem Cell & Regenerative Medicine Newsletter - Special Event Notice

Advancing a New Policy Framework for Regenerative Cell Therapy
Washington, D.C. – Cell therapies represent one of the most promising areas for the next generation of groundbreaking treatments in the areas of cardiology, neurology, oncology, ophthalmology, and orthopedics. Yet these treatments are generally not accessible to patients in the United States. Europe and Japan have outpaced the U.S. in modernizing their regulatory policies for the cell therapy. On Tuesday, April 12, the Bipartisan Policy Center and the Regenerative Medicine Foundation will convene a timely discussion on modernizing U.S. regulatory policies to accommodate rapidly emerging new technologies. Last month, bipartisan, bicameral legislation was introduced to create a new regulatory pathway to bring safe and effective cell therapy treatments to patients in the United States. The REGROW Act was also discussed during the Senate Health, Education, Labor, and Pensions (HELP) Committee’s third and final mark-up of medical innovation legislation this week.

Members of the press wishing to attend, please RSVP to Joann Donnellan jdonnellan@bipartisanpolicy.org

Join the discussion on Twitter: @BPC_Bipartisan #BPClive


Julie G. Allickson, PhD
Director, Regenerative Medicine Clinical Center
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine

Arnold Caplan, PhD
Professor, Case-Western Reserve University
Director, Skeletal Research Center

Deborah L. Dean
Executive Vice President and Chief Compliance Officer, MiMedx

Joanne Kurtzberg, MD
Professor of Pediatrics and Professor of Pathology, Duke University of Medicine
Chief Scientific Officer, Robertson Clinical and Translational Cell Therapy Program

C. Randal Mills, PhD
President and CEO, California Institute for Regenerative Medicine

Moderated by:

Janet Marchibroda
Director of Health Innovation, BPC

For a full list of participants, see here.

Sandy Barker
President and Co-Founder, Gold Rush Cure Foundation

Steven A. Davis, MD
Co-Founder and Chief Medical Officer, StemBioSys, Inc.

Joshua M. Hare, MD
Founding Director, Interdisciplinary Stem Cell Institute
Leonard M. Miller School of Medicine at the University of Miami

Leslie Miller, MD, FAHA, FACC
Chairman, Alliance for the Advancement of Cellular Therapies

Shelley Ross
President, The Cure Alliance

Bernard Siegel
Executive Director, Regenerative Medicine Foundation

Tuesday, April 12, 2016
9:30 a.m. - 12:00 p.m. ET

Bipartisan Policy Center
1225 Eye St. NW
Suite 1000
Washington, D.C. 20005

360 Newsletter Editor

Bernard Siegel
Executive Director
Regenerative Medicine Foundation

Bernard Siegel's TedX talk "Stem Cells and the Transformative Power of Hope"

About Regenerative Medicine Foundation

The nonprofit Regenerative Medicine Foundation (RMF) www.genpol.org, formerly known as the Genetics Policy Institute, is the catalyst and provides leadership to the pro-cures movement, an influential global network of stakeholders from patient-advocacy, science and industry. Through RMF’s action network, reports and newsletters, the flagship World Stem Cell Summit & RegMed Capital Conference, special projects, speaking engagements, world renowned advisory boards, educational resources, teaching initiatives and strategic relationships, RMF serves as the foremost channel of knowledge between leading regenerative medicine experts, patient advocates and those who make policy for the general public.

ConnectGPI on FacebookGPI on TwitterGPI on LinkedIn

World Stem Cell Summit & Regmed Capital Conference Overview

Domain: Medical
Category: Biology

Recent Newsletters

12 March, 2019
10 October, 2018
15 February, 2018